Produced by Araxis Merge on 4/12/2018 10:22:31 AM Central Daylight Time. See www.araxis.com for information about Merge. This report uses XHTML and CSS2, and is best viewed with a modern standards-compliant browser. For optimum results when printing this report, use landscape orientation and enable printing of background images and colours in your browser.
| # | Location | File | Last Modified |
|---|---|---|---|
| 1 | Thu Apr 12 15:22:30 2018 UTC | ||
| 2 | MSSRe Build 4.zip | 170025 - Monitor Clinical Quality Performance Metrics and Measures TS.docx | Thu Apr 12 14:58:34 2018 UTC |
| Description | Between Files 1 and 2 |
|
|---|---|---|
| Text Blocks | Lines | |
| Unchanged | 0 | 0 |
| Changed | 0 | 0 |
| Inserted | 1 | 273 |
| Removed | 0 | 0 |
| Whitespace | |
|---|---|
| Character case | Differences in character case are significant |
| Line endings | Differences in line endings (CR and LF characters) are ignored |
| CR/LF characters | Not shown in the comparison detail |
No regular expressions were active.
| 1 | 170025: Mo nitor Clin ical Quali ty Perform ance Metri cs and Mea sures TS | |||||
| 2 | ||||||
| 3 | Creation D ate: Mar 13, 2018 3 :39:10 PM (UTC-05:00 )Last Modi fied: Mar 16, 2018 9 :22:50 AM (UTC-05:00 ) | |||||
| 4 | ||||||
| 5 | State: Dra ft | |||||
| 6 | Originator : Collins , Joseph A . (Liberty )Owner: T ype: Manua l | |||||
| 7 | Test Data: Unassign ed Descrip tion: | |||||
| 8 | Summary | |||||
| 9 | ||||||
| 10 | Categories | |||||
| 11 | AHOBPR: Un assigned T est: Unass igned | |||||
| 12 | ||||||
| 13 | Formal Rev iew | |||||
| 14 | ||||||
| 15 | ||||||
| 16 | General Co mments | |||||
| 17 | ||||||
| 18 | Manual Ste ps | |||||
| 19 | ||||||
| 20 | ||||||
| 21 | Step 1 | |||||
| 22 | Execution Step | |||||
| 23 | ||||||
| 24 | Descriptio n* | |||||
| 25 | Browse to MSSR Patie nt Listing page http s://URL/ E xpected Re sults | |||||
| 26 | MSSRe land ing page i s displaye d | |||||
| 27 | ||||||
| 28 | Comments V alidates | |||||
| 29 | Attachment s | |||||
| 30 | ||||||
| 31 | ||||||
| 32 | Step 2 | |||||
| 33 | Execution Step | |||||
| 34 | ||||||
| 35 | Descriptio n* | |||||
| 36 | Click on ‘ Ok’ button on splash screen no tice page to continu e. | |||||
| 37 | Expected R esults | |||||
| 38 | MSSRe home page is d isplayed C omments | |||||
| 39 | Validates | |||||
| 40 | ||||||
| 41 | Attachment s | |||||
| 42 | ||||||
| 43 | ||||||
| 44 | Step 3 | |||||
| 45 | ||||||
| 46 | ||||||
| 47 | ||||||
| 48 | Execution Step | |||||
| 49 | ||||||
| 50 | Descriptio n* | |||||
| 51 | Patients’ page displ ays. | |||||
| 52 | Expected R esults | |||||
| 53 | List of pa tients is displayed Comments | |||||
| 54 | Validates | |||||
| 55 | ||||||
| 56 | Attachment s | |||||
| 57 | ||||||
| 58 | ||||||
| 59 | Step 4 | |||||
| 60 | Execution Step | |||||
| 61 | ||||||
| 62 | Descriptio n* | |||||
| 63 | Click on R eporting m enu. | |||||
| 64 | Expected R esults | |||||
| 65 | Focus is R eporting > Default C omments | |||||
| 66 | Validates | |||||
| 67 | ||||||
| 68 | Attachment s | |||||
| 69 | ||||||
| 70 | ||||||
| 71 | Step 5 | |||||
| 72 | Execution Step | |||||
| 73 | ||||||
| 74 | Descriptio n* | |||||
| 75 | Click on Q uality Per formance M etrics fro m the left menu | |||||
| 76 | Expected R esults | |||||
| 77 | Quality Pe rformance Metrics ar e displaye d Comments | |||||
| 78 | Validates | |||||
| 79 | ||||||
| 80 | Attachment s | |||||
| 81 | ||||||
| 82 | ||||||
| 83 | Step 6 | |||||
| 84 | Execution Step | |||||
| 85 | ||||||
| 86 | Descriptio n* | |||||
| 87 | Select fil ters and c lick View Results | |||||
| 88 | Expected R esults | |||||
| 89 | Charts/gri d data are filtered according to filter criteria p rovided Co mments | |||||
| 90 | Validates | |||||
| 91 | ||||||
| 92 | ||||||
| 93 | ||||||
| 94 | Attachment s | |||||
| 95 | ||||||
| 96 | ||||||
| 97 | Step 7 | |||||
| 98 | Execution Step | |||||
| 99 | ||||||
| 100 | Descriptio n* | |||||
| 101 | Verify | |||||
| 102 | 1.QI1-CIS should dis play perce ntage of p atients wi th – CIS a nd has eve r been pre scribed a DMT | |||||
| 103 | Expected R esults | |||||
| 104 | Indicator is display ed as stat ed above C omments | |||||
| 105 | Validates | |||||
| 106 | ||||||
| 107 | Attachment s | |||||
| 108 | ||||||
| 109 | ||||||
| 110 | Step 8 | |||||
| 111 | Execution Step | |||||
| 112 | ||||||
| 113 | Descriptio n* | |||||
| 114 | Verify | |||||
| 115 | 1.QI1-CIS OR NMO sho uld displa y percenta ge of pati ents with – CIS OR N MO and has ever been prescribe d a DMT | |||||
| 116 | Expected R esults | |||||
| 117 | Indicator is display ed as stat ed above C omments | |||||
| 118 | Validates | |||||
| 119 | ||||||
| 120 | Attachment s | |||||
| 121 | ||||||
| 122 | ||||||
| 123 | Step 9 | |||||
| 124 | Execution Step | |||||
| 125 | ||||||
| 126 | Descriptio n* | |||||
| 127 | Verify | |||||
| 128 | 1.QI1-PPMS should di splay perc entage of patients w ith – PPMS and has e ver been p rescribed a DMT | |||||
| 129 | Expected R esults | |||||
| 130 | Indicator is display ed as stat ed above C omments | |||||
| 131 | Validates | |||||
| 132 | ||||||
| 133 | Attachment s | |||||
| 134 | ||||||
| 135 | ||||||
| 136 | Step 10 | |||||
| 137 | Execution Step | |||||
| 138 | ||||||
| 139 | Descriptio n* | |||||
| 140 | Verify | |||||
| 141 | ||||||
| 142 | ||||||
| 143 | ||||||
| 144 | 1.QI1-PRMS should di splay perc entage of patients w ith – PRMS and has e ver been p rescribed a DMT | |||||
| 145 | Expected R esults | |||||
| 146 | Indicator is display ed as stat ed above C omments | |||||
| 147 | Validates | |||||
| 148 | ||||||
| 149 | Attachment s | |||||
| 150 | ||||||
| 151 | ||||||
| 152 | Step 11 | |||||
| 153 | Execution Step | |||||
| 154 | Descriptio n* Verify | |||||
| 155 | 1.QI1-RRMS should di splay perc entage of patients w ith – RRMS has ever been presc ribed a DM T | |||||
| 156 | Expected R esults | |||||
| 157 | Indicator is display ed as stat ed above C omments | |||||
| 158 | Validates | |||||
| 159 | ||||||
| 160 | Attachment s | |||||
| 161 | ||||||
| 162 | ||||||
| 163 | Step 12 | |||||
| 164 | Execution Step | |||||
| 165 | Descriptio n* Verify | |||||
| 166 | 1.QI1-SPMS should di splay perc entage of patients w ith – SPMS and has e ver been p rescribed a DMT | |||||
| 167 | Expected R esults | |||||
| 168 | Indicator is display ed as stat ed above C omments | |||||
| 169 | Validates | |||||
| 170 | ||||||
| 171 | Attachment s | |||||
| 172 | ||||||
| 173 | ||||||
| 174 | Step 13 | |||||
| 175 | Execution Step | |||||
| 176 | ||||||
| 177 | Descriptio n* | |||||
| 178 | Verify QI2 -CIS shoul d display percentage of patien ts with – CIS and is currently prescribe d a DMT | |||||
| 179 | ||||||
| 180 | Expected R esults | |||||
| 181 | Indicator is display ed as stat ed above C omments | |||||
| 182 | Validates | |||||
| 183 | ||||||
| 184 | ||||||
| 185 | ||||||
| 186 | Attachment s | |||||
| 187 | ||||||
| 188 | ||||||
| 189 | Step 14 | |||||
| 190 | Execution Step | |||||
| 191 | Descriptio n* Verify | |||||
| 192 | 1.QI2-CIS OR NMO sho uld displa y percenta ge of pati ents with – CIS OR N MO and is currently prescribed a DMT | |||||
| 193 | Expected R esults | |||||
| 194 | Indicator is display ed as stat ed above C omments | |||||
| 195 | Validates | |||||
| 196 | ||||||
| 197 | Attachment s | |||||
| 198 | ||||||
| 199 | ||||||
| 200 | Step 15 | |||||
| 201 | Execution Step | |||||
| 202 | Descriptio n* Verify | |||||
| 203 | 1.QI2-PPMS should di splay perc entage of patients w ith – PPMS and is cu rrently pr escribed a DMT | |||||
| 204 | Expected R esults | |||||
| 205 | Indicator is display ed as stat ed above C omments | |||||
| 206 | Validates | |||||
| 207 | ||||||
| 208 | Attachment s | |||||
| 209 | ||||||
| 210 | ||||||
| 211 | Step 16 | |||||
| 212 | Execution Step | |||||
| 213 | Descriptio n* Verify | |||||
| 214 | 1.QI2-PRMS should di splay perc entage of patients w ith – PRMS and is cu rrently pr escribed a DMT | |||||
| 215 | Expected R esults | |||||
| 216 | Indicator is display ed as stat ed above C omments | |||||
| 217 | Validates | |||||
| 218 | ||||||
| 219 | Attachment s | |||||
| 220 | ||||||
| 221 | ||||||
| 222 | Step 17 | |||||
| 223 | Execution Step | |||||
| 224 | Descriptio n* Verify | |||||
| 225 | 1.QI2-RRMS should di splay perc entage of patients w ith – RRMS and is cu rrently pr escribed a DMT | |||||
| 226 | ||||||
| 227 | ||||||
| 228 | ||||||
| 229 | Expected R esults | |||||
| 230 | Indicator is display ed as stat ed above C omments | |||||
| 231 | Validates | |||||
| 232 | ||||||
| 233 | Attachment s | |||||
| 234 | ||||||
| 235 | ||||||
| 236 | Step 18 | |||||
| 237 | Execution Step | |||||
| 238 | Descriptio n* Verify | |||||
| 239 | 1.QI2-SPMS should di splay perc entage of patients w ith – SPMS and is cu rrently pr escribed a DMT | |||||
| 240 | Expected R esults | |||||
| 241 | Indicator is display ed as stat ed above C omments | |||||
| 242 | Validates | |||||
| 243 | ||||||
| 244 | Attachment s | |||||
| 245 | ||||||
| 246 | ||||||
| 247 | Step 19 | |||||
| 248 | Execution Step | |||||
| 249 | Descriptio n* Verify | |||||
| 250 | 1.QI-3 sho uld displa y percenta ge of pati ents with – EDMUS sc ore of 6 o r greater should be prescribed an assist ive device | |||||
| 251 | Expected R esults | |||||
| 252 | Indicator is display ed as stat ed above C omments | |||||
| 253 | Validates | |||||
| 254 | ||||||
| 255 | Attachment s | |||||
| 256 | ||||||
| 257 | ||||||
| 258 | Step 20 | |||||
| 259 | Execution Step | |||||
| 260 | Descriptio n* Verify | |||||
| 261 | 1.QI-4 sho uld displa y percenta ge of pati ents with – MS patie nts with a diagnosis of depres sion shoul d be seen in mental health | |||||
| 262 | Expected R esults | |||||
| 263 | Indicator is display ed as stat ed above C omments | |||||
| 264 | Validates | |||||
| 265 | ||||||
| 266 | ||||||
| 267 | ||||||
| 268 | Attachment s | |||||
| 269 | ||||||
| 270 | Associated E-Signatu res | |||||
| 271 | ||||||
| 272 | ||||||
| 273 | SignedActi onSignerCo mmentAddit ional Info rmation |
Araxis Merge (but not the data content of this report) is Copyright © 1993-2016 Araxis Ltd (www.araxis.com). All rights reserved.